[Skip to Content]
[Skip to Content Landing]
September 6, 1965

Choice of Treatment for Cervix Cancer: Radiosensitivity Testing

JAMA. 1965;193(10):826-827. doi:10.1001/jama.1965.03090100072023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Contributions to modern radiotherapy by the radiobiologist and radiation physicist, and the rapid advancement in modern surgical adjuvents, including anesthesiology, blood banks, antibiotics, and ever increasing capacity to correct the chemical imbalance of operative stress, have brought us to an era where we have two excellent, but not perfect, modalities of treatment for carcinoma of the cervix. There is no doubt that skillful radiation or surgical therapy can attain a high rate of cure in stage I and stage II tumors.

With the peculiar adaptability of the female reproductive organs to the reception of radium, the generally radiosensitive nature of these tumors, and the relatively low morbidity associated with the radiotherapeutic treatment, one would think that this should continue to be the standard treatment for this disease. Yet, in centers where teams of physicians experienced in this area, including the cytologist, pathologist, gynecologist, and radiotherapist, pool their skills so that

First Page Preview View Large
First page PDF preview
First page PDF preview